GPR137B

Across TCGA pan-cancer cohorts, GPR137B mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated GPR137B data layer compared with 23 for mass-spec protein and 4 for mutation status.

The strongest signal is observed in lung squamous cell carcinoma (LSCC), where higher GPR137B mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated GPR137B expression acts as an unfavorable survival marker.

LSCC and GBM are the cancer types where GPR137B mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LSCC	OS	Tertile	II,III,IV	0.484	0.865	.031	2	view →
GBM	OS	Quartile	All	0.378	0.600	.040	1	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

GPR137B–LSCC (OS)

Open the LSCC breakdown →